We are live on ! Find out more
GWM

Geneos Wealth Management Portfolio holdings

AUM $4.9B
1-Year Est. Return 23.65%
This Fund
S&P 500
This Quarter Est. Return
+6.34%
1 Year Est. Return
+23.65%
3 Year Est. Return
+66.72%
5 Year Est. Return
+71.27%
10 Year Est. Return
+298.51%
AUM
$2.62B
AUM Growth
+$368M
Cap. Flow
+$229M
Cap. Flow %
8.75%
Top 10 Hldgs %
18.1%
Holding
2,638
New
585
Increased
1,008
Reduced
426
Closed
81

Sector Composition

Rank Sector Weight
1 Technology 8.21%
2 Financials 4.98%
3 Healthcare 4.3%
4 Consumer Discretionary 3.17%
5 Industrials 3.08%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
RGLD icon
1801
Royal Gold
RGLD
$19.5B
$11.1K ﹤0.01%
79
+24
+44% +$3.28K
RPHS
1802
DELISTED
Regents Park Hedged Market Strategy ETF
RPHS
$11.1K ﹤0.01%
1,068
FCNCA icon
1803
First Citizens BancShares
FCNCA
$25.3B
$11K ﹤0.01%
6
-34
-85% -$64.9K
RFV icon
1804
Invesco S&P MidCap 400 Pure Value ETF
RFV
$336M
$11K ﹤0.01%
93
-300
-76% -$34.3K
CPB icon
1805
Campbell Soup
CPB
$6.87B
$11K ﹤0.01%
+225
New +$10.9K
LNW
1806
DELISTED
Light & Wonder
LNW
$11K ﹤0.01%
121
PFGC icon
1807
Performance Food Group
PFGC
$18B
$11K ﹤0.01%
+140
New +$9.81K
HOPE icon
1808
Hope Bancorp
HOPE
$1.79B
$10.9K ﹤0.01%
870
+801
+1,161% +$9.79K
FHN icon
1809
First Horizon
FHN
$12.1B
$10.9K ﹤0.01%
703
+553
+369% +$8.78K
TEF
1810
DELISTED
Telefonica
TEF
$10.9K ﹤0.01%
+2,246
New +$10.2K
ALEX
1811
DELISTED
Alexander & Baldwin
ALEX
$10.8K ﹤0.01%
565
+65
+13% +$1.23K
MSM icon
1812
MSC Industrial Direct
MSM
$6.86B
$10.8K ﹤0.01%
126
-136
-52% -$11.1K
NBIX icon
1813
Neurocrine Biosciences
NBIX
$16.6B
$10.8K ﹤0.01%
+94
New +$12.9K
AAXJ icon
1814
iShares MSCI All Country Asia ex Japan ETF
AAXJ
$3.77B
$10.8K ﹤0.01%
138
MLI icon
1815
Mueller Industries
MLI
$15.2B
$10.8K ﹤0.01%
+292
New +$9.78K
PIZ icon
1816
Invesco Dorsey Wright Developed Markets Momentum ETF
PIZ
$756M
$10.8K ﹤0.01%
285
CVY icon
1817
Invesco Zacks Multi-Asset Income ETF
CVY
$124M
$10.8K ﹤0.01%
413
HDB icon
1818
HDFC Bank
HDB
$121B
$10.7K ﹤0.01%
342
+268
+362% +$8.24K
RL icon
1819
Ralph Lauren
RL
$23.6B
$10.7K ﹤0.01%
55
+5
+10% +$865
COLB icon
1820
Columbia Banking Systems
COLB
$8.84B
$10.7K ﹤0.01%
+408
New +$9.72K
TS icon
1821
Tenaris
TS
$26.8B
$10.7K ﹤0.01%
+335
New +$9.94K
UPRO icon
1822
ProShares UltraPro S&P 500
UPRO
$5.7B
$10.6K ﹤0.01%
123
FRA icon
1823
BlackRock Floating Rate Income Strategies Fund
FRA
$385M
$10.6K ﹤0.01%
800
CNX icon
1824
CNX Resources
CNX
$5.2B
$10.6K ﹤0.01%
324
+94
+41% +$2.53K
BBVA icon
1825
Banco Bilbao Vizcaya Argentaria
BBVA
$156B
$10.5K ﹤0.01%
973
+862
+777% +$8.97K

Similar funds

Geneos Wealth Management's Q3 2024 Portfolio in Review

As of Q3 2024, Geneos Wealth Management held 2,638 positions worth $2.62B, up 16% from $2.25B the previous quarter. Its ten largest holdings account for 18% of the portfolio.

Geneos Wealth Management deployed $229M of net new capital in Q3 2024, opening 585 new positions and adding to 1,008 existing holdings. Its largest new stake was iShares Core MSCI International Developed Markets ETF: 104,319 shares worth $7.39M.

By sector, the portfolio is most concentrated in Technology at 8.2% of assets, down from 8.7% a quarter earlier, followed by Financials and Healthcare.

On the sell side, the largest reduction was iShares 20+ Year Treasury Bond ETF, an estimated $11.9M trimmed.

  • Geneos Wealth Management's largest Q3 2024 buy was iShares Core MSCI International Developed Markets ETF: 104,319 shares worth $7.39M.
  • Geneos Wealth Management added most to PGIM Ultra Short Bond ETF in Q3 2024, an estimated $9.4M increase.
  • Geneos Wealth Management's biggest Q3 2024 reduction was iShares 20+ Year Treasury Bond ETF, cutting an estimated $11.9M.
  • Geneos Wealth Management fully exited iShares MSCI Germany ETF in Q3 2024, selling an estimated $2.37M.
  • Geneos Wealth Management's ten largest holdings make up 18% of its $2.62B portfolio in Q3 2024.
  • Geneos Wealth Management opened 585 new positions and closed 81 in Q3 2024.
  • Geneos Wealth Management's portfolio value rose 16% quarter-over-quarter to $2.62B.

Based on Geneos Wealth Management's 13F filing for Q3 2024, filed 14 Nov 2024.